Clinical Trials in Yufu, Japan

3 recruiting

Showing 110 of 10 trials

Recruiting
Phase 3

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC1,440 enrolled282 locationsNCT06925737
Recruiting
Phase 3

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Adult Acute Myeloid Leukemia
Priothera SAS366 enrolled108 locationsNCT05429632
Recruiting
Phase 1

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Parkinson Disease
Eli Lilly and Company127 enrolled14 locationsNCT06809400
Recruiting
Phase 3

Study of Out of Specification for Tisagenlecleucel

Diffuse Large B Cell LymphomaB-cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals200 enrolled53 locationsNCT04094311
Recruiting
Phase 1

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Parkinson's Disease
Prevail Therapeutics108 enrolled4 locationsNCT06565195
Recruiting

Special Drug Use-results Surveillance of Tafinlar/Mekinist

BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor
Novartis Pharmaceuticals110 enrolled68 locationsNCT06262919
Recruiting
Phase 3

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Cancer
Bayer402 enrolled383 locationsNCT04464226
Recruiting
Phase 2

ONO-4538 Phase II Rollover Study (ONO-4538-98)

Pan-tumor
Ono Pharmaceutical Co., Ltd.59 enrolled38 locationsNCT04566380
Recruiting
Phase 3

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer

Rectal Cancer Recurrent
National Cancer Center Hospital East110 enrolled45 locationsNCT04288999
Recruiting
Phase 3

Phase III Trial of Stage I Ovarian Cancer After Surgery

Epithelial Ovarian Cancer
Japanese Gynecologic Oncology Group360 enrolled103 locationsNCT04063527